Appropriate treatment receipt after breast-conserving surgery
- PMID: 30607122
- PMCID: PMC6291280
- DOI: 10.3747/co.25.4117
Appropriate treatment receipt after breast-conserving surgery
Abstract
Background: Breast-conserving surgery (bcs) and radiation therapy (rt) are the standard of care for early breast cancer, although some women receive ipsilateral mastectomy or adjuvant tamoxifen, both of which can be appropriate alternatives to rt. Objectives of the present study were to determine the proportion of women who are treated appropriately after bcs and to identify factors associated with non-receipt of rt.
Methods: This retrospective cohort study used Ontario data linked at the Institute for Clinical and Evaluative Sciences to examine 33,718 patients who received bcs during 2004-2010. Primary outcome was rt receipt. The ipsilateral mastectomy rate and patient, surgeon, and setting variables were measured.
Results: Of the study patients, 86.1% received either rt or completion mastectomy; in the cohort less than 70 years of age, 90.8% received rt or completion mastectomy. Among patients less than 70 years of age, 3 risk factors for non-receipt of rt were identified: age less than 46 years, treatment in a non-academic institution, and earlier year of initial bcs. Additionally, in the overall cohort, rt non-receipt was associated with high comorbidity, more than 40 km to the cancer centre, income quintile, and breast care specialization.
Conclusions: In Ontario, 90.8% of patients less than 70 years of age are appropriately treated for early breast cancer; approximately 1 in 10 do not receive rt or completion mastectomy. Based on those findings, women less than 46 years of age might be at increased risk of recurrence and death because of incomplete treatment. It also appears that academic centres more effectively treat breast cancer; however, breast cancer care appears to be improving over time in Ontario.
Keywords: Radiation; breast cancer; surgery.
Conflict of interest statement
CONFLICT OF INTEREST DISCLOSURES We have read and understood Current Oncology’s policy on disclosing conflicts of interest, and we declare that we have none.
Figures
Similar articles
-
Associated Factors and Survival Outcomes for Breast Conserving Surgery versus Mastectomy among New Zealand Women with Early-Stage Breast Cancer.Int J Environ Res Public Health. 2021 Mar 8;18(5):2738. doi: 10.3390/ijerph18052738. Int J Environ Res Public Health. 2021. PMID: 33800387 Free PMC article.
-
Disparities in the Initial Local Treatment of Older Women with Early-Stage Breast Cancer: A Population-Based Study.J Womens Health (Larchmt). 2017 Jul;26(7):735-744. doi: 10.1089/jwh.2015.5639. Epub 2017 Feb 7. J Womens Health (Larchmt). 2017. PMID: 28170302 Free PMC article.
-
Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis.Breast Cancer Res Treat. 2019 Aug;176(3):657-667. doi: 10.1007/s10549-019-05266-0. Epub 2019 May 10. Breast Cancer Res Treat. 2019. PMID: 31076954
-
Mortality impact of less-than-standard therapy in older breast cancer patients.J Am Coll Surg. 2008 Jan;206(1):66-75. doi: 10.1016/j.jamcollsurg.2007.07.015. Epub 2007 Oct 3. J Am Coll Surg. 2008. PMID: 18155570
-
Contemporary treatment of ductal carcinoma in situ of the breast.Med Sci Monit. 2005 Mar;11(3):RA86-93. Med Sci Monit. 2005. PMID: 15735580 Review.
Cited by
-
Recurrence and mortality after breast-conserving surgery without radiation.Curr Oncol. 2019 Dec;26(6):380-388. doi: 10.3747/co.26.5225. Epub 2019 Dec 1. Curr Oncol. 2019. PMID: 31896936 Free PMC article.
-
Qualitative exploration of patients' experiences with Intrabeam TARGeted Intraoperative radioTherapy (TARGIT-IORT) and External-Beam RadioTherapy Treatment (EBRT) for breast cancer.BMJ Open. 2024 Aug 20;14(8):e081222. doi: 10.1136/bmjopen-2023-081222. BMJ Open. 2024. PMID: 39164104 Free PMC article.
References
-
- Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995;333:1456–61. doi: 10.1056/NEJM199511303332203. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical